Mersana Therapeutics Inc

NASDAQ:MRSN   3:37:48 PM EDT
6.48
-0.05 (-0.77%)
Earnings Announcements

Mersana Therapeutics Reports Q3 Loss Per Share Of $0.61

Published: 11/07/2022 12:37 GMT
Mersana Therapeutics Inc (MRSN) - Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results.
Mersana Therapeutics Inc Q3 Loss per Share $0.61.
Mersana Therapeutics Inc Q3 of 2022 Collaboration Revenue $5.6 Million.
Mersana Therapeutics Inc - Expects That Its Available Funds Will Be Sufficient to Support Its Operating Plan Commitments Into First Half of 2024.
Revenue is expected to be $10.28 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $10 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.